FOR HEALTHCARE PROFESSIONALS ONLY

This website is a global information resource. It is intended for healthcare professionals only outside of the United States of America (US) who are interested in information on Foundation Medicine®. This site is not intended to provide medical advice and/or treatment guidance. If you are a US healthcare professional click here.

This site is produced by Roche as a partner of Roche Foundation Medicine.

You are leaving

Dear visitor,
Please note that you are now leaving www.foundationmedicine.my

 

 

Orange

 

 

 

Our service for diagnostic, prognostic and predictive insights to support treatment of haematological malignancies and sarcomas.1

DNA and RNA  sequencing    Uses both DNA and RNA  sequencing for sensitive detection  of translocations and fusions    1 >400 genes,  TMB, MSI    Analyses >400  cancer-related genes and   reports TMB and MSI 1
Order

Order FoundationOne Heme

In Malaysia, accepted specimen types is FFPE block or slides. FoundationOne Heme is available in Malaysia for Sarcomas with specimen type in the form of FFPE block or slides. Because blood and bone marrow aspirate must be received the day after collection for optimal analysis.2 Malaysia may not be able to offer the FoundationOne Heme service for blood and bone marrow aspirate at this moment. We are working to make FoundationOne Heme more broadly available.

FFPE, formalin-fixed paraffin-embedded. MSI, microsatellite instability. TMB, tumour mutational burden.
References
  1. FoundationOne®Heme Technical Specifications, 2017. Available at: www.foundationmedicine.com/genomic-testing/foundation-one-heme (Accessed March 2019).
  2. FoundationOne®Heme Specimen Instructions, 2017. Available at: www.foundationmedicine.com/genomic-testing/foundation-one-heme (Accessed March 2019).